Literature DB >> 30650360

Muscle Stem Cells Give Rise to Rhabdomyosarcomas in a Severe Mouse Model of Duchenne Muscular Dystrophy.

Francesca Boscolo Sesillo1, David Fox2, Alessandra Sacco3.   

Abstract

Most human cancers originate from high-turnover tissues, while low-proliferating tissues, like skeletal muscle, exhibit a lower incidence of tumor development. In Duchenne muscular dystrophy (DMD), which induces increased skeletal muscle regeneration, tumor incidence is increased. Rhabdomyosarcomas (RMSs), a rare and aggressive type of soft tissue sarcoma, can develop in this context, but the impact of DMD severity on RMS development and its cell of origin are poorly understood. Here, we show that RMS latency is affected by DMD severity and that muscle stem cells (MuSCs) can give rise to RMS in dystrophic mice. We report that even before tumor formation, MuSCs exhibit increased self-renewal and an expression signature associated with RMSs. These cells can form tumorspheres in vitro and give rise to RMSs in vivo. Finally, we show that the inflammatory genes Ccl11 and Rgs5 are involved in RMS growth. Together, our results show that DMD severity drives MuSC-mediated RMS development.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer; muscle stem cells; muscular dystrophy; rhabdomyosarcoma; self-renewal; skeletal muscle

Mesh:

Year:  2019        PMID: 30650360      PMCID: PMC6853774          DOI: 10.1016/j.celrep.2018.12.089

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  77 in total

Review 1.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

Review 2.  Cancer initiation and progression: involvement of stem cells and the microenvironment.

Authors:  Berit B Tysnes; Rolf Bjerkvig
Journal:  Biochim Biophys Acta       Date:  2007-02-09

3.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

4.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

5.  Regulator of G protein signaling 5 (RGS5) inhibits sonic hedgehog function in mouse cortical neurons.

Authors:  Chuanliang Liu; Qiongqiong Hu; Jia Jing; Yun Zhang; Jing Jin; Liulei Zhang; Lili Mu; Yumei Liu; Bo Sun; Tongshuai Zhang; Qingfei Kong; Guangyou Wang; Dandan Wang; Yao Zhang; Xijun Liu; Wei Zhao; Jinghua Wang; Tao Feng; Hulun Li
Journal:  Mol Cell Neurosci       Date:  2017-07-03       Impact factor: 4.314

6.  Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis.

Authors:  Aaron W B Joe; Lin Yi; Anuradha Natarajan; Fabien Le Grand; Leslie So; Joy Wang; Michael A Rudnicki; Fabio M V Rossi
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

7.  Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.

Authors:  Koichi Nishijo; Qing-Rong Chen; Lei Zhang; Amanda T McCleish; Andrea Rodriguez; Min Jung Cho; Suresh I Prajapati; Jonathan A L Gelfond; Gary B Chisholm; Joel E Michalek; Bruce J Aronow; Frederic G Barr; R Lor Randall; Marc Ladanyi; Stephen J Qualman; Brian P Rubin; Robin D LeGallo; Chiayeng Wang; Javed Khan; Charles Keller
Journal:  Cancer Res       Date:  2009-04-01       Impact factor: 12.701

8.  Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.

Authors:  Eleanor Y Chen; Michael T DeRan; Myron S Ignatius; Kathryn Brooke Grandinetti; Ryan Clagg; Karin M McCarthy; Riadh M Lobbardi; Jillian Brockmann; Charles Keller; Xu Wu; David M Langenau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

9.  Anesthesia for Duchenne muscular dystrophy patients: case reports.

Authors:  Rodrigo Machado Saldanha; Juliano Rodrigues Gasparini; Letícia Sales Silva; Roberto Rigueti de Carli; Victor Ugo Dorigo de Castilhos; Mariana Moraes Pereira das Neves; Fernando Paiva Araújo; Paulo César de Abreu Sales; José Francisco Nunes Pereira das Neves
Journal:  Rev Bras Anestesiol       Date:  2005-08       Impact factor: 0.964

10.  Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma.

Authors:  S Satheesha; G Manzella; A Bovay; E A Casanova; P K Bode; R Belle; S Feuchtgruber; P Jaaks; N Dogan; E Koscielniak; B W Schäfer
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

View more
  12 in total

1.  Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.

Authors:  Francesca Boscolo Sesillo; Alessandra Sacco
Journal:  J Vis Exp       Date:  2019-09-13       Impact factor: 1.355

Review 2.  From Development to Aging: The Path to Cellular Senescence.

Authors:  Alessandra Sacco; Laura Belloni; Lucia Latella
Journal:  Antioxid Redox Signal       Date:  2020-05-05       Impact factor: 8.401

3.  Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model.

Authors:  Ruizhong Wang; Brijesh Kumar; Poornima Bhat-Nakshatri; Mayuri S Prasad; Max H Jacobsen; Gabriela Ovalle; Calli Maguire; George Sandusky; Trupti Trivedi; Khalid S Mohammad; Theresa Guise; Narsimha R Penthala; Peter A Crooks; Jianguo Liu; Teresa Zimmers; Harikrishna Nakshatri
Journal:  JCSM Rapid Commun       Date:  2020-07-15

4.  Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.

Authors:  Andreas von Deimling; Christian Koelsche; Felix K F Kommoss; Damian Stichel; Jaume Mora; Manel Esteller; David T W Jones; Stefan M Pfister; Eva Brack; Marco Wachtel; Peter Karl Bode; Hans-Peter Sinn; Dietmar Schmidt; Thomas Mentzel; Friedrich Kommoss; Felix Sahm
Journal:  Mod Pathol       Date:  2021-04-12       Impact factor: 7.842

Review 5.  The Duchenne muscular dystrophy gene and cancer.

Authors:  Leanne Jones; Michael Naidoo; Lee R Machado; Karen Anthony
Journal:  Cell Oncol (Dordr)       Date:  2020-11-14       Impact factor: 6.730

6.  Isolation of muscle stem cells from rat skeletal muscles.

Authors:  Francesca Boscolo Sesillo; Michelle Wong; Amy Cortez; Marianna Alperin
Journal:  Stem Cell Res       Date:  2019-12-10       Impact factor: 2.020

7.  Constricted migration modulates stem cell differentiation.

Authors:  Lucas R Smith; Jerome Irianto; Yuntao Xia; Charlotte R Pfeifer; Dennis E Discher
Journal:  Mol Biol Cell       Date:  2019-06-12       Impact factor: 4.138

Review 8.  Perspectives on skeletal muscle stem cells.

Authors:  F Relaix; M Bencze; M J Borok; A Der Vartanian; F Gattazzo; D Mademtzoglou; S Perez-Diaz; A Prola; P C Reyes-Fernandez; A Rotini
Journal:  Nat Commun       Date:  2021-01-29       Impact factor: 14.919

9.  Loss of p16/Ink4a drives high frequency of rhabdomyosarcoma in a rat model of Duchenne muscular dystrophy.

Authors:  Naomi Teramoto; Masanari Ikeda; Hidetoshi Sugihara; Takanori Shiga; Takashi Matsuwaki; Masugi Nishihara; Kazuyuki Uchida; Keitaro Yamanouchi
Journal:  J Vet Med Sci       Date:  2021-07-31       Impact factor: 1.267

10.  Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.

Authors:  Julia Bauer; Nicole Cuvelier; Nada Ragab; Katja Simon-Keller; Frauke Nitzki; Natalie Geyer; Dominik S Botermann; Dominik P Elmer; Albert Rosenberger; Thomas A Rando; Stefano Biressi; James A Fagin; Dieter Saur; Christian Dullin; Hans-Ulrich Schildhaus; Walter Schulz-Schaeffer; Fritz Aberger; Anja Uhmann; Heidi Hahn
Journal:  Oncogene       Date:  2021-06-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.